Study Shows Novel Effects of Eucerin Active Ingredient Complex on Atopic Dermatitis

Beiersdorf researchers in collaboration with the Dermatological Clinic of the University of Lübeck have shown in a double-blind clinical study that the AtopiControl ingredient complex including licochalcone, a from the licorice root and omega-6 fatty acids from evening primrose oil and grape seed oi,l is much more than just a common basic care product.

"In our clinical study over the course of up to 84 days adult volunteers with a history of mild to moderate atopic dermatitis, who were symptom free at the time, applied to each arm either the AtopiControl lotion or the lotion base without the active ingredients", says Beiersdorf researcher and physician Dr. Frank Rippke. "Neither the study participants nor the doctors knew which side was treated with the active formulation and which side with the active-free lotion base." The results are outstanding: "Compared to the lotion base, the AtopiControl lotion led to a significantly longer symptom-free interval until the next acute flare. We were able to prove, for the first time, that the symptom-free interval in cases of atopic dermatitis can be extended by medical skin care actives", says Dr. Rippke.

"This clinical study impressively shows that AtopiControl with its active ingredient complex can create real relief for atopic dermatitis sufferers", says Gitta Neufang. "The results emphasize our research competence and increase the credibility of the Eucerin brand immensely, especially with our important multipliers, doctors and pharmacists."

The study results were presented in October 2015 at the European Dermatological Congress (EADV) in Copenhagen and will also be published in a dermatological journal.

"This study is quite meaningful for health professionals because we were not only able to show a new stabilizing effect of the active ingredients on the atopic skin condition; furthermore, we used a completely new methodology. The challenge was that we couldn't rely on any previous studies of this kind and so it was difficult to estimate our chance of success in advance", says Dr. Rippke. "But the results confirmed that we were right."